In our study, carriers of APOE-ɛ4 had higher levels of tTau and pTau181 and lower levels of Aβ42 and Aβ42/Aβ40 ratio in the CSF (Table 3), which also reflects an AD-linked pattern. Here, APOE is linked to Alzheimer disease.